Načítá se...
Profile of veliparib and its potential in the treatment of solid tumors
Inhibition of poly(ADP-ribose) polymerase (PARP) is an attractive therapeutic strategy because of the importance of this pathway in restoring DNA damage. Small-molecule inhibitors of PARP appear most effective when used to treat tumors with underlying defects in DNA repair, or when combined with DNA...
Uloženo v:
| Vydáno v: | Onco Targets Ther |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4524591/ https://ncbi.nlm.nih.gov/pubmed/26251615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S69935 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|